Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.46 |
| ▸ | HRH1 | P35367 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6578290 | 0.93 | CYP17A1 (0.36) | HTR2AHRH1LMNATDP1POLB | |
| SCHEMBL54346 | 0.85 | HTR2A (0.59) | HTR2AHRH1LMNATDP1TAAR1 | |
| SCHEMBL29268835 | 0.83 | HTR2A (0.56) | HTR2AHRH1LMNATDP1TAAR1 | |
| Phosphine SCHEMBL28948486 | 0.83 | HTR2A (0.56) | HTR2AHRH1LMNATDP1TAAR1 | |
| SCHEMBL12506256 | 0.83 | HTR2A (0.56) | HTR2AHRH1LMNATDP1TAAR1 | |
| Ammonia Solution, Strong SCHEMBL10389261 | 0.83 | HTR2A (0.56) | HTR2AHRH1LMNATDP1TAAR1 | |
| Ammonia Solution, Strong SCHEMBL5683105 | 0.83 | HTR2A (0.56) | HTR2AHRH1LMNATDP1TAAR1 | |
| Methane SCHEMBL28250836 | 0.83 | HTR2A (0.56) | HTR2AHRH1LMNATDP1TAAR1 | |
| SCHEMBL7918988 | 0.83 | HRH1 (0.45) | HTR2AHRH1LMNATDP1TAAR1 | |
| Dimethylamine SCHEMBL8170436 | 0.78 | HTR2A (0.54) | HTR2AHRH1LMNATDP1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1115284-A1 | ANTIFOULING AGENTS | Phycogen, Inc. (US) | 2001-07-18 | — | — | EP | claimed |
| EP-1115285-A1 | SAFE AND EFFECTIVE BIOFILM INHIBITORY COMPOUNDS AND HEALTH-RELATED USES THEREOF | Phycogen, Inc. (US) | 2001-07-18 | — | — | EP | claimed |
| EP-1115289-A2 | ENVIRONMENTALLY BENIGN CROP PROTECTION AGENTS | Phycogen, Inc. (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2000016632-A2 | ENVIRONMENTALLY BENIGN CROP PROTECTION AGENTS | PHYCOGEN, INC. (US) | 2000-03-30 | — | — | WO | claimed |
| WO-2000016623-A1 | ANTIFOULING AGENTS | PHYCOGEN, INC. (US) | 2000-03-30 | — | — | WO | claimed |
| WO-2000016624-A1 | SAFE AND EFFECTIVE BIOFILM INHIBITORY COMPOUNDS AND HEALTH-RELATED USES THEREOF | PHYCOGEN, INC. (US) | 2000-03-30 | — | — | WO | claimed |
| WO-2023222443-A1 | POLYSILOXANE-POLYCARBONATE BLOCK CO-CONDENSATES FORMED FROM SPECIFICALLY TERMINATED SILOXANE BLOCKS | COVESTRO DEUTSCHLAND AG (DE) | 2023-11-23 | — | — | WO | disclosed |
| WO-2021122509-A1 | METHOD FOR THE PRODUCTION OF A POLYESTER CARBONATE | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2021-06-24 | — | — | WO | disclosed |
| US-8932735-B2 | Aromatic amine derivative and organic electroluminescent element comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-01-13 | — | — | US | disclosed |
| US-20130306957-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO ., LTD. (JP) | 2013-11-21 | — | — | US | disclosed |
| EP-2645443-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Idemitsu Kosan Co., Ltd. (JP) | 2013-10-02 | — | — | EP | disclosed |
| EP-2423179-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| EP-1115284-A1 | ANTIFOULING AGENTS | Phycogen, Inc. (US) | 2001-07-18 | — | — | EP | disclosed |
| EP-1115394-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING DERIVATIVES OF SULPHUR ACIDS | Phycogen, Inc. (US) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000016623-A1 | ANTIFOULING AGENTS | PHYCOGEN, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
| WO-2000016764-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING DERIVATIVES OF SULPHUR ACIDS | PHYCOGEN, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | AOC2, AOC3, H1-4 | HTR2A 2221/4885HRH1 501/4885LMNA 625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.